University of Michigan Rogel Cancer Center

Site:	University of Michigan Rogel Cancer Center	Go to their website
Address:	1500 East Medical Center Dr Floor B1, Reception E
City:	Ann Arbor
State:	MI
Zip:	48109
Country:	USA

Phase	Trial	Trial Status	Site Status [asc]	Drug	NCT#
1	Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas	Active, not recruiting	Closed	INBRX-109 + Temozolomide	NCT03715933
2	Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors	Completed	Not yet activated	Linsitinib (OSI-906)	NCT01560260